Hypertension limbo: Balancing benefits, harms, and patient preferences before we lower the bar on blood pressure

Annals of Internal Medicine

Volumn 168, Issue 5, 2018, Pages 369-370

  Wilt, Timothy J ^a   Kansagara, Devan ^b   Qaseem, Amir ^c  

^a VA MEDICAL CENTER   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

^c AMERICAN COLLEGE OF PHYSICIANS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; EDITORIAL; FOLLOW UP; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HUMAN; HYPERTENSION; KIDNEY DISEASE; LIFESTYLE MODIFICATION; OBSERVATIONAL STUDY; PATIENT PREFERENCE; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; SYSTOLIC BLOOD PRESSURE; ADULT; MEDICAL SOCIETY; UNITED STATES;

ADULT; AMERICAN HEART ASSOCIATION; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; HUMANS; HYPERTENSION; PATIENT PREFERENCE; UNITED STATES;

EID: 85042922868     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M17-3293     Document Type: Editorial

References (10)

1. Carey RM, Whelton PK; 2017 ACC/AHA Hypertension Guideline Writing Committee. Prevention, detection, evaluation, and management of high blood pressure in adults: synopsis of the 2017 American College of Cardiology/American Heart Association hypertension guideline. Ann Intern Med. 2018;168:351-8. doi:10.7326/M17-3203
2. Qaseem A, Wilt TJ, Rich R, Humphrey LL, Frost J, Forciea MA; Clinical Guidelines Committee of the American College of Physicians and the Commission on Health of the Public and Science of the American Academy of Family Physicians. Pharmacologic treatment of hypertension in adults aged 60 years or older to higher versus lower blood pressure targets: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med. 2017;166:430-7. PMID: 28135725 doi:10.7326/M16-1785
3. Doust J, Vandvik PO, Qaseem A, Mustafa RA, Horvath AR, Frances A, et al; Guidelines International Network (G-I-N) Preventing Overdiagnosis Working Group. Guidance for modifying the definition of diseases: a checklist. JAMA Intern Med. 2017;177:1020-5. PMID: 28505266 doi:10.1001/jamainternmed.2017.1302
4. Welch HG, Schwartz LM, Woloshin S. Overdiagnosed: Making People Sick in the Pursuit of Health. Boston: Beacon Pr; 2011:1-31.
5. Haynes RB, Sackett DL, Taylor DW, Gibson ES, Johnson AL. Increased absenteeism from work after detection and labeling of hypertensive patients. N Engl J Med. 1978;299:741-4. [PMID: 692548]
6. Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, et al; SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103-16. PMID: 26551272 doi:10.1056/NEJMoa1511939
7. Wei Y, Jin Z, Shen G, Zhao X, Yang W, Zhong Y, et al. Effects of intensive antihypertensive treatment on Chinese hypertensive patients older than 70 years. J Clin Hypertens (Greenwich). 2013;15: 420-7. [PMID: 23730991] doi:10.1111/jch.12094
8. Lonn EM, Bosch J, López-Jaramillo P, Zhu J, Liu L, Pais P, et al; HOPE-3 Investigators. Blood-pressure lowering in intermediate-risk persons without cardiovascular disease. N Engl J Med. 2016;374: 2009-20. [PMID: 27041480] doi:10.1056/NEJMoa1600175
9. Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998;351:1755-62. [PMID: 9635947]
10. Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348:1556-64. [PMID: 12700376]